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Introduction
Incisional hernia is the most common complication of laparo-
tomies, with a cumulative incidence of about 20% [1–3]. It occurs
when the abdominal wall heals incompletely and impedes the
timely re-establishment of an efficient load-bearing scar at the
myofascial layer. Patient- and technical-related risk factors have
been identified [4]. However, the molecular mechanisms that con-
trol its formation remain ambiguous. The late appearance after
laparotomy and the recurrence rate curves observed after opera-
tion strongly suggest a biological underlying dysfunction, at least
in a subset of patients [5, 6]. Interest has mainly focused on
abnormal collagen metabolism, and a number of studies have
investigated changes in type I to type III collagen ratios [7, 8] and
alterations in individual matrix metalloprotenaises (MMPs) [7–9]
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Abstract
Background: Incisional hernia is a common and important complication of laparotomies. Epidemiological studies allude to an under-
lying biological cause, at least in a subset of population. Interest has mainly focused on abnormal collagen metabolism. However,
the role played by other determinants of extracellular matrix (ECM) composition is unknown. To date, there are few laboratory
 studies investigating the importance of biological factors contributing to incisional hernia development. We performed a descriptive
tissue-based analysis to elucidate the possible relevance of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) 
in association with local cytokine induction in human incisional hernia tissues. The expression profiles of MMPs, TIMPs and  
pro-inflammatory cytokine signalling were investigated in aponeurosis and skeletal muscle specimens taken intraoperatively from
incisional hernia (n  10) and control (n  10) patients. Semiquantitative RT-PCR, zymography and immunoblotting analyses were
done. Incisional hernia samples displayed alterations in the microstructure and loss of ECM, as assessed by histological analyses.
Moreover, incisional hernia tissues showed increased MMP/TIMP ratios and de-regulated inflammatory signalling (tumor necrosis
factor [TNFA] and interleukin [IL]-6 tended to increase, whereas aponeurosis TNFA receptors decreased). The changes were tissue-
specific and were detectable at the mRNA and/or protein level. Statistical analyses showed several associations between individual
MMPs, TIMPs, interstitial collagens and inflammatory markers. The increment of MMPs in the absence of a counterbalance by
TIMPs, together with an ongoing de-regulated inflammatory signalling, may contribute in inducing a functional defect of the ECM
network by post-translational mechanisms, which may trigger abdominal wall tissue loss and eventual rupture. The notable TIMP3
protein down-regulation in incisional hernia fascia may be of pathophysiological significance. We conclude that this study may help
to pinpoint novel hypotheses of pathogenesis that can lead to a better understanding of the disease and ultimately to improvement
in current therapeutic approaches.
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and collagen-interacting proteins [10]. Nevertheless, as the majority of
hernias occur in patients that have no history of a wound-healing
defect (making them safe surgical candidates) and also do not
express a defect at the primary surgical site [6], other triggers are
feasible. Some studies provide experimental evidence relating
mechanical failure and incisional hernia development (reviewed  in
reference 7), possibly as a consequence of altered mechanotrans-
duction and repair fibroblast biology [7, 11]. Other mechanisms
have so far received little attention. It is possible that new descrip-
tive tissue-based research may help to establish novel hypotheses
of pathogenesis. For instance, the relevance of local factors intrinsic
to the target tissue, like an ongoing induction of pro-inflammatory
mediators or persistent extracellular matrix (ECM) turnover, is
still unknown.
The balance between MMPs and tissue inhibitors of metallo-
proteinase (TIMPs) is a critical determinant of ECM integrity and
function. Alterations in MMPs/TIMPs ratios are implicated in 
multiple diseases [12]. De-regulated specific MMPs expression
has been previously reported in incisional hernia [7, 9]. Because
studies have usually focused on a single MMP (MMP1, MMP13
[7] and MMP2 [9]) and there are no reports concerning TIMPs
measurement, there is a need to perform a more comprehensive
survey of MMPs and TIMPs to study them in a more integrated
fashion, because it is the concerted action of the MMPs and
TIMPs that determines their biological actions.
Also, cytokines are important regulators of MMPs/TIMPs sys-
tems. In the setting of surgical stress, cytokines and other factors
are released with consequent autocrine/paracrine actions [13, 14].
Initially decisive for the host recovery, the persistence of de-
 regulated inflammatory signalling may be detrimental. ECM is
 critical in fine-tuning the spatial and temporal expression patterns
of cytokines at sites of inflammation and healing [15, 16].
Finally, incisional hernia affects both the skeletal muscle and
the fascial layers. To date, the fascia has been focused on in
most of the investigations [17], but it is probable that insights
into disease pathogenesis may be gained by simultaneously
analysing both tissues. Skeletal muscle is a load-bearing struc-
ture that confers abdominal wall compliance. It is highly respon-
sive to changes in functional demands, but it has been scarcely
studied in relation to incisional hernia in human cases. Because
the skeletal muscle is especially sensitive to pro-inflammatory
stimuli, responding with tissue loss and failure [18], we hypoth-
esized that it may effectively contribute to incisional hernia 
formation if persistently challenged by a continuous exposition to
increased pro-inflammatory gene products, thus being a potential
therapeutic target.
The aim of this study was basically exploratory to generate new
biologically plausible hypotheses into how, in a pathophysiological
sense, incisional hernia formation and local tissue microenviron-
ment can be linked. In particular, we wanted to observe whether in
incisional hernia patients: (1) there is a local tissue-specific pattern
of changes in the ECM proteolytic system characterized by ongoing
increased MMPs/TIMPs ratios, that is, a profile known to impair
ECM turnover and favour ECM degradation; and (2) the abdominal
myofascial tissues (fascia and skeletal muscle) participate in the




Samples included in this study were selected from our incisional hernia
tissue bank. The tissue bank stores fascia and skeletal muscle biopsies
obtained from the abdominal wall tissues of incisional hernia patients and
non-incisional hernia controls and data associated with them, such as
demographic features, co-morbidities, etc. Specimens are taken intraoper-
atively at the Department of Surgery of the Hospital Universitari Vall
d’Hebron, by a specialized surgeon (incisional hernia samples are collected
at repair, at 8 cm of the edge of the defect). The areas of visible necrosis
or granulation tissue are intentionally avoided. The biopsies are immediately
divided into multiple pieces and fixed in 10% formalin for histopathologi-
cal analyses or snap-frozen in liquid nitrogen until analysis. Only in relation
to specific research projects are DNA, RNA and proteins isolated from the
solid tissue for downstream applications.
The patient characteristics are described in Table 1. Incisional hernias
were diagnosed in the outpatient clinic by physical examination. Previous
operations leading to primary incisional hernia formation included resec-
tion of colon or rectal tumour (n  8) and cholecystectomy (n  2). To our
knowledge, the patients did not experience immediate major post-opera-
tive complications. The interval between prior laparotomy and repair was 
69  32 months (range 13–252 months; 13 months, n  4; 14 months, 
n  3; 96 months, n  1; 252 months, n  2). All the hernias were in the
midline. Hernia repair was performed with an open onlay technique. The
size of the defect is not available. Reference tissue samples were obtained
from voluntary donors undergoing elective digestive abdominal surgery.
Patients with previous wound infections or those with diabetes or connec-
tive or systemic inflammatory diseases were not included in this study. The
research protocol was reviewed and approved by the institutional ethics
committee. Written informed consent was obtained from all participants.
Table 1 Patient characteristics







(n  10) (n  10)
Age  SEM (range) 61  4 (42–72) 55  3 (43–69) 0.19
Male sex 7 7 1.00
Smokers 3 2 1.00




Diabetes 0 0 1.00
Hyperlipidaemia 1 1 1.00
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Histology and immunohistochemistry
Biopsies for histology and immunohistochemistry were immediately fixed in
10% neutral buffered formaldehyde and embedded in paraffin. Consecutive
sections (4-m-thick) were cut and stained with haematoxylin and eosin to
visualize the morphology, Masson’s trichrome to determine collagenous com-
ponents and Alcian blue (pH 2.5) to estimate glycosaminoglycans (GAGs)
abundance, as performed in routine clinical practice. For immunohistochem-
istry, paraffin-embedded sections were deparaffinized and rehydrated with
xylene and a graded alcohol series. Endogenous peroxidases were blocked by
incubation with 2% H2O2 for 30 min. Antigen retrieval was performed in 
0.01 mol/l sodium citrate buffer (pH 6.0) with an electric pressure cooker. The
tissue sections were blocked in serum-blocking solution and staining was
performed with anti--SMA (Clone 1A4, 1:100; Dako M0851, Dako
Diagnósticos, Barcelona, Spain) as primary antibody [19]. Detection was
completed with the avidin–biotin complex peroxidase method (ABC Elite kit;
Vector, Burlingame, CA, USA) followed by 3,3-diaminobenzidine tetrachlo-
ride staining (DAB; Sigma, Deisenhofen, Germany) and haematoxylin counter-
staining. Negative controls consisted in the omission of the primary antibody.
An experienced soft-tissue pathologist from the Vall d’Hebron University
Hospital Department of Pathology (P.H.), who was blinded to the clinical
diagnosis, examined the biopsy specimens. The samples were characterized
in detail based on haematoxylin and eosin- and Masson’s trichrome-stained
slides. The staining intensities of Masson’s trichrome and Alcian blue stains
preparations were assessed visually and graded semiquantitatively. A
minimum of three sections (10 randomly chosen, non-contiguous and no
overlapping high-power fields each) were examined per patient.
RNA extraction and RT-PCR
Total RNA was extracted with TRIzol reagent, using a single-step method
(Invitrogen, Barcelona, Spain). The RNA quality and quantity were
assessed with a 2100 Bioanalyzer (Agilent, Madrid, Spain). RNA was
reverse transcribed with the use of Superscript II reverse transcriptase
(Invitrogen) and random primers. The PCR protocols were performed with
cDNA products, human-specific primers, and 1 U of TaqDNA polymerase
(Invitrogen), as depicted in Table 2. The Multiplex PCR Kit for Human MMP
Table 2 Sequences of PCR primers
Primers were generated with the Primer 3 software (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and were mRNA/cDNA-specific.
Preliminary experiments were conducted to ensure that the number of cycles represented a linear portion for the PCR optical density (OD) curve.
The specificity of each primer pair was verified by sequencing the amplified products. PCR cycles were as follows: 25 (TIMP2 aponeuroses), 
27 (MMP2 and TIMP3), 28 (COL1A1 aponeuroses), 29 (RPL19), 30 (TIMP1 and COL4A1; and TIMP2 and TIMP3 muscles), 31 (TNFSFR1B and
COL3A1; and COL1A1 muscles), 32 (MMP2 muscles), 35 (MMP14, TIMP4, TNFA and TNFSFR1A; and IL-6 aponeuroses), 36 (IL-6 muscles), 
37 (MMP9 aponeuroses) or 40 (MMP9 muscles).
COL1A1, collagen, type I, alpha-1; COL3A1, collagen, type III, alpha-1; COL4A1, collagen, type IV, alpha 1.
Group Gene
Primer sequence forward 5	3
(exon)





Collagens COL1A1 GTCTTCCTGGCCCCTCTGGTG (40) TCGCCCTGTTCGCCTGTCTCA (45) 390 NM_000088
COL3A1 CAGGGGCCCCAGGACTTAGAG (30) GGGCCAGGAGGACCAATAGGT (33) 249 NM_000090
COL4A1 CAATGCCCTTCCTGTTCTGC (51) GTGGACGGCGTAGGCTTCTT (53~54) 451 NM_001845
MMPs MMP2 ACATCAAGGGCATTCAGGAG (8) TGAACCGGTCCTTGAAGAAG (9~10) 168 NM_004530
MMP9 GGGAAGATGCTGCTGTTCA (11) TCAACTCACTCCGGGAACTC (13) 202 NM_004994
MMP14 GCAGAAGTTTTACGGCTTGC (2) CTTGGGGGTGTAATTCTGGA (4) 199 NM_004995
TACE/ADAM-17 TCATTGACCAGCTGAGCATC (17) CGCAGGAAAGGGTTTGATAA (20) 233 NM_003183
TIMPs TIMP1 CTGCGGATACTTCCACAGGT (3) GTTTGCAGGGGATGGATAAA (5) 209 NM_003254
TIMP2 GATGCACATCACCCTCTGTG (4) GTGCCCGTTCATGTTCTTCT (5) 196 NM_003255
TIMP3 CTGACAGGTCGCGTCTATGA (3~4) AGTCACAAAGCAAGGCAGGT (5) 165 NM_000362
TIMP4 CTTGGTGCAGAGGGAAAGTC (4) GGCTGAACGATGTTCAACAAA (5) 249 NM_003256
Cytokines and receptors TNFA CAGAGGGCCTGTACCTCATC (2) GGAAGACCCCTCCCAGATAG (4) 219 NM_000594
TNFSFR1A GTGCCTACCCCAGATTGAGA (7) TGTCGATTTCCCACAAACAA (8~9) 175 NM_001065
TNFSFR1B GGAAACTCAAGCCTGCACTC (4) TGCAAATATCCGTGGATGAA (5) 224 NM_001066
IL-6 CCACACAGACAGCCACTCAC (2) TTTCACCAGGCAAGTCTCCT (3) 217 NM_000600
Ribosomal RPL19 CAATGCCAACTCCCGTCAGC (1~2) CTTGGTCTCTTCCTCCTTGG (6) 487 NM_000981
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Genes Set-1 (Maxim Biotech, Inc., Madrid, Spain) was used to amplify
MMP1, MMP3, MMP7, MMP13 and glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) cDNAs. The PCR products were separated on 2%
agarose gels, visualized with ethidium bromide and quantified by densito-
metry (Quantity One Quantitation Software™; Bio-Rad, Barcelona, Spain).
The results were expressed as a ratio between signals corresponding to the
gene of interest and ribosomal protein L19 (RPL19; or GAPDH for
Multiplex kit genes). All samples received pooled reagents and compar-
isons were made only with simultaneously performed experiments.
Negative controls were done with omission of retrotranscription.
Tissue extraction and immunoblotting
The muscle tissues were homogenized in Tissue-PE LB™ lysis buffer
(GenoTechnology, Inc., Barcelona, Spain) containing protease inhibitors
(Set III, 1:100; Calbiochem, Barcelona, Spain) and centrifuged (12,000
 g,
20 min.). The supernatants were collected, and the pellets were further dis-
solved in RIPA buffer (50mM Tris-HCl pH 7.6, 150 mM NaCl, 1 mM ethyl-
enediaminetetraacetic acid [EDTA], 0.25% sodium deoxycolate, 1% Triton
X-100, 2% SDS, plus protease inhibitors), centrifuged and the super-
natants collected. Aponeuroses were homogenized in RIPA buffer and 
centrifuged (12,000
 g, 20 min.). The supernatants were collected and
concentrated with Ultrafree®-MC devices (Millipore, Madrid, Spain).
Protein levels were quantified (BCA Protein Assay; Pierce, Madrid, Spain).
Equal amounts of total protein were size-fractioned in 7.5, 10, 12 or 15%
SDS-PAGE under reducing conditions (20 mA/gel; RT), transferred
overnight to nitrocellulose membranes (60 V, 4C), and stained with red
Ponceau. The membranes were blocked in TBST buffer (0.9% NaCl,
0.02 M Tris, pH 7.5, 0.05% Tween 20) and 10% skimmed milk (1 hr, RT)
before incubation with the respective anti-human primary antibodies:
Clone I-8H5 (1:40, 1:20) for collagen I, Clone III-53 (1:100) for collagen III,
Clone 41–1E5 (1:50) for MMP1 and Clone 136–13H4 (1:20) for TIMP3,
from Calbiochem; tumor necrosis factor-alpha converting enzyme
(TACE)/ADAMT17 (catalogue no. AB19027; 1:1000) and Clone loop no.
3pAb (1:200) for TIMP4, from Chemicon Int. (Madrid, Spain); Clone T3
(1:10) for TNFA, Clone H398 (1:10) for tumor necrosis factor receptor
superfamily, member 1A (TNFRSF1A) and Clone 80M2 (1:10) for tumor
necrosis factor receptor superfamily, member 1B (TNFRSF1B), from
HyCult Biotech (Madrid, Spain); and Clone pAb 1:666 for interleukin 
(IL)-6, from R&D Systems (Madrid, Spain). Detection was performed with
appropriate peroxidase-labelled secondary antibodies. An enhanced
chemiluminescence kit (Amersham, Barcelona, Spain) was used to detect
immunoreactive bands.
Zymography and reverse zymography analyses
Equal protein quantities diluted in denaturing non-reducing Laemmli buffer
were resolved on SDS-PAGE gels co-polymerized with gelatin (7.5%, 
1.5 mg/ml), casein (10%, 1.5 mg/ml) or carboxymethylated transferrin
(10%, 1 mg/ml), as described previously [19]. The gels were washed,
incubated (37C, 22 hrs) in substrate buffer and stained. TIMPs activities
were analysed by reverse zymography [20] under non-reducing condi-
tions. For reverse zymography, equal protein quantities were loaded on
12% SDS-PAGE gels impregnated with both 2.5 mg/ml gelatin and gelati-
nase A (1.2 g/10 ml of gel; Oncogene, Barcelona, Spain). The gels were
run, washed and incubated likewise gelatin zymography, excepting incubation
time (37C, 15 hrs). Proteolytic activities were quantified by densitometry
scanning (Quantity One Quantitation Software™).
Statistical analysis
Data were quantified as means  standard error (SE). Differences between
group means were analysed using the two-way unpaired Student’s t-test or
the Mann–Whitney U-test, after checking the homogeneity of variances.
Categorical data were analysed by Fisher’s exact test. Multi-variate data
analyses (principal component analysis [PCA] and multiple regression
analysis) were performed with data obtained from RT-PCR to unravel potential
relationships between transcripts. We extracted principle components (PCs)
separately from aponeurosis and muscle. PCA is a simple, non-parametric
method, which was used as an exploratory tool to reduce the dimensionality
of the data set [21]. Backward stepwise multiple regression analysis (with
entry criteria of P  0.10, adjusted by group) was performed to determine
possible significant associations between individual genes. A P-value of less
than 0.05 was considered significant. A P-value between 0.05 and 0.10 was
considered to indicate a trend towards an association.
Results
Table 1 shows patient characteristics at biopsy collection. Of inter-
est, age, sex and co-morbidities were not statistically different
between the control and the incisional hernia groups. All patients
in this study had developed a primary incisional hernia after a pre-
vious operation. Thus, samples were collected when the patients
were treated for their first incisional hernia repair when meshes
were not present.
Histological analysis
The fascial layer consisted of a small number of fibroblasts, ves-
sels and a large ECM. Compared with controls (Fig. 1A), incisional
hernia fascias (Fig. 1B) showed histoarchitecture damage and loss
of ECM, together with a tendency towards more rounded fibro -
blasts and disruption of the cell–matrix contacts. Incisional hernia
skeletal muscle was characterized by a higher deposition of con-
nective tissue in the endomysium, together with a higher percent-
age of fibres with centrally located nuclei (Fig. 1D). No signs of
infection were seen. Histological evidence of inflammatory infiltra-
tion or granulation tissue was negligible in all samples studied.
Interestingly, Alcian blue staining (pH 2.5) was increased in hernia
samples (data not shown).
ECM synthesis and degradation
Some degree of up-regulated interstitial collagen mRNA expres-
sion was observed in incisional hernia samples, although, at the
statistical level, only a trend towards increased skeletal muscle
collagen, type III, alpha-1 (COL3A1) transcripts was detected 
(P  0.093; Fig. 2). Discordant levels were observed at the pro-
tein level, which may be ascribable to partially inefficient protein
extraction and solubilization.
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Conversely, changes in MMPs and TIMPs expression were
identified in incisional hernia tissues both at the transcriptional
and at the post-transcriptional levels (Figs. 2 and 3). These
changes resulted in higher MMP/TIMP ratios (Fig. 4), which is
consistent with a net MMP system activation. Specifically, inci-
sional hernia specimens displayed increased RNA transcripts for
MMP1 (P  0.055) in aponeurosis, and for MMP2 (P  0.074),
MMP9 (P  0.045) and MMP14 (P  0.016) in skeletal muscle,
and reduced RNA transcripts for MMP13 (P  0.001), MMP3 
(P  0.060) and TIMP4 (P  0.036) in aponeuroses, and for
TIMP3 (P  0.012) in skeletal muscle. Significant gene expres-
sion results were further corroborated by enzyme assays and
immunoblotting to determine activities and amounts of MMPs and
TIMPs. So, active MMP1 (43 kD) was overexpressed (muscle 
P  0.014, aponeurosis P  0.031), and TIMP3 (24 kD) was
underexpressed (muscle P  0.080, aponeurosis P  0.008) in
incisional hernia samples, as assessed by immunoblotting (Figs. 2
and 3). Zymography and reverse zymography (Figs. 2 and 3)
revealed a strong induction of MMP9 (92 kD and 86 kD, P 
0.026) and MMP3 (P  0.040) activities, together with largely
decreased TIMPs activities in incisional hernia aponeuroses (P 
0.015). Under the conditions used (and probably due to the fact
that muscle ECM protein is minimal as compared with total pro-
tein), MMPs and TIMPs activities were undetectable in skeletal
muscle specimens.
Pro-inflammatory signalling
As shown in Figs. 2 and 3, TNFA and IL-6 transcripts tended to
increase in incisional hernia (TNFA: aponeurosis P  0.064, skeletal
muscle P  0.077; IL-6: skeletal muscle P  0.097). TNFA 
receptors mRNA expression tended to decrease in incisional her-
nia aponeuroses (TNFRSF1A P  0.071, TNFRSF1B P  0.063),
whereas TNFRSF1A tended to increase in skeletal muscle 
(P  0.089). At the protein level, IL-6 (P  0.056) and TNFA 
(P  0.099) tended to be up-regulated in incisional hernia skele-
tal muscle. A striking down-regulation of the 40 kD highly soluble
TNFRSF1B protein was observed in incisional hernia aponeuroses
(P  0.022). Noteworthy, only the soluble 17 kD TNFA protein
(sTNFA) was detected in muscle, whereas, in the aponeurosis,
exclusively low levels of 26 kD mTNFA protein were obtained.
Finally, IL-6 protein was highly embedded in the ECM, and it was
only rescued by strong extraction procedures.
Statistical relationships between transcripts
Complex networks of reciprocal interactions are established
between MMPs, TIMPs, cytokines and growth factors, which reg-
ulate a wide variety of inflammatory and tissue remodelling medi-
ators [22]. As it is difficult to compare the expression pattern of
the 17 molecules simultaneously, PCA was performed. PCA is a
powerful, exploratory non-parametric tool that has found applica-
tion in several fields to extract relevant information from multi-
dimensional data sets, that is, it filters out the noise and reveals
hidden structure, allowing the selection of the most useful vari-
ables [21, 23]. By observing the correlations between the indices
and the original variables (factor loadings), associations between
the original variables can be identified and summarized. Factor
loadings revealed the genes that provided the largest positive and
negative contribution to incisional hernia (loading  0.6). Each
correlation or loading indicates how strongly the original variable
‘loads’ on it. As depicted in Table 3, the PCA included in this report
Fig. 1 Representative haematoxylin and eosin-
stained sections. As compared with controls
(A), incisional hernia aponeuroses (B) are char-
acterized by a loss of ECM organization, tissue
wasting and more rounded fibroblasts. Incisional
hernia muscles (D) display higher endomysial
connective tissue deposition and more fibres
with centrally located nuclei than control mus-
cles (C). Original magnification, 
400.
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identifies interstitial collagens, TIMPs, MMPs (MMP1, MMP9 and
MMP14) and TNF receptors as closely associated to the incisional
hernia phenotype in a tissue-specific manner. Finally, several predic-
tive models were constructed using different combinations of vari-
ables by backward multiple regression analysis. The most effective
ones are described in Table 4 and yield interesting insights into the
co-regulation of gene sets within the TNF and MMP marker families.
Discussion
We performed a tissue-based, exploratory molecular survey to
gain a better understanding of the role of local tissue microenvi-
ronment in patients with a clinical history of incisional hernia. Our
major novel findings were that in incisional hernia: (1) the consti-
tutive baseline MMPs/TIMPs quotients are significantly higher, (2)
there is a trend towards de-regulated pro-inflammatory cytokine
content and signalling and (3) both the aponeurosis and the skeletal
muscle are affected and exhibit multiple tissue-specific alterations.
Because biopsies were obtained avoiding the hernia ring, the
results point to the presence of subclinical events reflected sys-
temically. Also, this study seems to be one of the first to explore
human skeletal muscle samples in this disease.
Limited information is available on MMPs and TIMPs expres-
sion within human abdominal wall tissues. Here, we showed that,
in hernia, the MMPs/TIMPs balance was altered in favour of net
proteolytic activity, which may alter the ECM network by 
Fig. 2 Representative RT-PCR,
Western blot and zymography
analyses obtained in incisional
hernia and control tissues. (A)
MMPs and TIMPs, (B) colla-
gens (types I, III and IV) and
type I to type III collagen ratios
and (C) inflammatory mediators
(TNFA, TNFRSF1A, TNFRSF1B
and IL-6). Results are displayed
graphically using percentages
of change of each molecule
(incisional hernia versus non-
incisional hernia controls) to
facilitate the interpretation of the
results. Only detectable results
are represented. ~P value 0.05–
0.10, *P value 0.05–0.01, **P
value 0.01–0.001, ***P value
 0.001. , aponeurosis; ,
skeletal muscle.
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post-translational mechanisms and contribute to incisional hernia
development. The apparent failure to replace connective tissue
with newly synthesized material could be ascribed to inefficient
collagen synthesis [24, 25]. Also, albeit not mechanistically inves-
tigated here, the lack of collagen deposition could be due to
improper extracellular post-translational collagen maturation sec-
ondary to cytokine action [26].
Among the MMPs analysed, stands out the elevated expres-
sion of MMP1, MMP3 and MMP9 in incisional hernia fascia, espe-
cially at the activity level. Because tissue biopsies failed to show
any inflammatory exudates, we speculate that they may be pro-
duced by native mesenchymal cells subtly stimulated by an unre-
lenting inflammatory signalling [27, 28]. MMP1 plays a unique
role in eliminating defective pro-collagens during new collagen
Fig. 3 (A) Representative RT-PCR products obtained in incisional hernia and control tissues. Only statistically significant transcripts are displayed
(aponeurosis: MMP1, TIMP4, TNFA, TNFRSF1A, TNFRSF1B and RPL19; skeletal muscle: MMP9, TIMP3, TNFA, TNFRSF1A, IL-6, RPL19), c  Multiplex®
PCR control, provided by the manufacturer. (B) Representative immunoblotting analyses obtained in incisional hernia and control specimens. Only sta-
tistically significant blots are presented (aponeurosis: MMP1, TIMP3 and soluble TNFRSF1B; skeletal muscle: MMP1, TIMP3, TNFA and IL-6), c  MMP1
control provided by Sigma. (C) Representative gelatinolytic (left), caseinolytic activity (right, up) and reversed zymography (right, down) in aponeuro-
sis tissues. A concentrate of serum-free-conditioned medium (SFCM) from human skin fibroblasts treated with TPA (Sigma-Aldrich, Barcelona, Spain)
was added to each gel to serve as a positive control. Only results obtained in aponeurosis are presented.
J. Cell. Mol. Med. Vol 13, No 11-12, 2009
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Fig. 4 MMP/TIMP mRNA ratios obtained in incisional hernia and control tissues. (A) aponeurosis and (B) skeletal muscle. ~P value 0.05–0.10, *P
value 0.05–0.01, **P value 0.01–0.001, ***P value  0.001 (incisional hernia versus control values). , incisional hernia; , non-incisional hernia.
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formation [29], and its anomalous activity has been associated
with progression of several diseases including congenital
diaphragmatic hernia lungs [30, 31]. MMP3 acts as an activator
for several MMPs, and it can directly stimulate cellular transfor-
mation [32]. MMP9 is important in the inflammatory phase of
wound healing [33, 34], and its excessive production relates to 
tissue damage and matricryptin generation, as observed in degen-
erative inflammatory and/or autoimmune disorders [35, 36].
Previous studies did not measure TIMPs expression in the her-
niated abdominal wall, excepting a sole report describing
Table 3 Loading factors
Non-incisional hernia Incisional hernia
Aponeurosis Aponeurosis
PC1 PC2 PC1 PC2
MMP14 0.973 TNFRSF1B 0.966 COL3A1 	0.842 COL1A1 0.880
MMP1 0.934 TIMP4 0.933 TNFRSF1A 0.835 TIMP2 0.867
TNF 0.933 MMP1 	0.814 MMP9 	0.827
TIMP3 0.926 TIMP4 0.797 TIMP1 0.754
MMP7 0.920 TIMP3 0.730 MMP14 0.740









Skeletal muscle Skeletal muscle
PC1 PC2 PC1 PC2
MMP3 0.900 TIMP4 0.740 MMP9 	0.978 TNF 0.979
TIMP2 0.896 MMP2 0.666 TIMP2 0.921 COL1A1 0.871
MMP7 0.893 TIMP3 0.901 COL3A1 0.846
MMP14 	0.886 MMP14 	0.871 TIMP4 0.786








Representative loading factors (0.6) of the first two principal components (PCs) for non-incisional hernia and incisional hernia in aponeurosis
and skeletal muscle.
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decreased TIMP2 levels within the fascia transversalis of inguinal
hernia [37]. A unique finding of the present study was TIMP3
down-regulation. TIMP3 is single among TIMPs in that it binds
firmly to and is localized in the ECM, where it influences matrix
remodelling and cell survival and inhibits matrix MMPs, aggre-
canases and TNFA-converting enzyme (TACE, ADAM17) [38, 39].
Mice deficient in TIMP3 have elevated levels of TACE/ADAM17 and
TNFA [40–42]. Not initially investigated, during manuscript prepa-
ration, we measured TACE levels. TACE mRNA expression did not
differ between both groups (data not shown), but immunoblotting
revealed a tendency towards increased active TACE (80 kD) in inci-
sional hernia skeletal muscle (≈50%, P  0.075), suggestive of
TACE post-transcriptional activation. Although it is not clear yet
whether this TIMP3 down-regulation is a primary defect or the
result of the loss of ECM content and structure, it could partially
account for the transition to tissue rupture by providing a direct
mechanistic link between inflammation and degradation. Future
researches in this field may allow unravelling these questions.
Another interesting and novel finding reported here is the de-
regulated expression of pro-inflammatory cytokines and receptors
within incisional hernia tissues. Inflammation is a crucial compo-
nent of the host response to tissue injuries, but if unnecessarily
persistent, it may be detrimental [43]. TNFA is involved in the
pathogenesis of chronic inflammation in vivo [44, 45] and is one
of the most important inducers of MMP protein production [27].
The specific effects of TNFA are signalled via TNFRSF1A and
Stepwise backward multiple regression was performed with an F-ratio probability of 0.10 as the criterion for removal or inclusion in the model. G  0,
incisional hernia (IH) group; G  1, non-IH group.
Dependent variables: TNF, TNFRSF1A, TNFRSF1B (aponeurosis) and TNFRSF1A (skeletal muscle).
G, group; B, estimate of the change in the dependent variable attributable to a change of one unit in the independent variable; P, significance; R 2,
R-squared.
Aponeurosis Skeletal muscle
B P % change R 2 B P % change R 2
TNF TNFRSF1A
Intercept 38.67 0.007 Intercept 192.46 0.000
MMP9 0.21 0.002 38 MMP9 	0.93 0.001 31
MMP1 0.19 0.018 17 MMP7 7.06 0.011 14
MMP3 2.27 0.026 15 MMP2 0.51 0.015 12
MMP13 	4.82 0.074 8 MMP3 	46.98 0.046 8
Group 2.79 
 G 0.810 0 Group 	12.30 
 G 0.089 5
Adjusted R 2  0.78; P  0.003 Adjusted R 2  0.78; P  0.003
TNFRSF1A
Intercept 54.42 0.007
MMP14 0.57 0.010 19
MMP1 	0.12 0.080 7
MMP3 	1.07 0.078 7
Group 15.94 
 G 0.040 10
Adjusted R2  0.43; P  0.046
TNFRSF1B
Intercept 34.07 0.000
MMP13 3.44 0.028 26
MMP9 0.12 0.031 24
Group 	8.13 
 G 0.421 3
Adjusted R 2  0.43; P  0.046
Table 4 Backward multiple regression analysis
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TNFRSF1B. TNFRSF1B, which mediates TNFA effects in a
paracrine/autocrine manner, was strongly down-regulated in inci-
sional hernia fascia. The selective modulation of TNFRSF1B may
represent a mechanism for protecting the host against the local
deleterious effects of TNFA [46–48]. Interestingly, TNFA has also a
role in mediating muscle loss in patients with chronic wasting
conditions, inflammatory myopathies and insulin resistance [18,
49, 50]. The trend towards increased TNFA levels in hernia could
also help to explain the more vigorous expression of IL-6 in inci-
sional hernia skeletal muscle through a stimulatory mechanism
for its secretion [51] (simple correlation analyses confirmed that
TNFA and IL-6 expression is highly interrelated in skeletal muscle,
r  0.595, P  0.020). IL-6 up-regulates the cathepsin and ubiqui-
tin pathways of muscle proteolysis [52]. Collectively, these results
raise the hypothesis that the tissue remodelling and destruction
detected in incisional hernia may be related, at least in part, to the
excessive cytokine production, which favours a state of chronic
low-grade molecular inflammatory status, even in the absence of
inflammatory cell exudates [43]. Also, it emphasizes the role of
the skeletal muscles as a potential target in incisional hernia.
Concerning the limitations of this study, analyses were per-
formed with an observational design and therefore inferences
regarding causal pathways cannot be conclusively drawn.
Investigating the aetiology of complex traits represents a major
challenge, and observational research is a valuable investigative
tool, providing rapid results at low cost. One major disadvantage
is that descriptive studies do not give any indication of the
absolute risk of the factor in question, but if the evidence found is
convincing enough, resources can be then allocated to further
more comprehensive studies. Also, although many hernias
become manifest early, others may not be noted until many years
after the index procedure. Thus, it is not easy to choose appropri-
ate ‘matched’ controls. A group of patients who had not developed
incisional hernia after a previous abdominal operation but were
laparatomized for other medical indications could have been
added as an additional control. However, even in this case, a 
hernia too small to be detected clinically may have been present.
Also, we could not discard that these patients would develop an inci-
sional defect in the (near) future. Finally, we cannot reject that the
changes observed in gene expression are also due to a loss of
mechanotransduction, secondary to connective tissue mechanical
unloading [6], and/or to a loss of fibroblast–ECM attachment [24, 53].
In summary, the results of the present study are consistent
with the hypothesis of a biology of hernia formation [5, 6].
Although studies with samples directly acquired from human
patients usually do not achieve the level of mechanicistic depth
and/or proof of causality than those using more tractable animal
and in vitro systems, our findings indicate that, in addition to a
fundamental biological disorder, such as abnormal collagen
metabolism, other molecular mechanisms are implicated in the
pathogenesis of incisional hernias and might be amenable to ther-
apeutic modification (i.e. the control of collagen synthesis alone
would not be sufficient to control progressive incisional hernia for-
mation, if cytokine de-regulation persists beyond the short-term
inflammatory host-response period). Thus, it seems likely that the
ongoing changes in MMPs/TIMPs profiles and pro-inflammatory
signalling seen in the present study are compartmentalized
processes that occur concomitantly in vivo and probably play a
role in the pathogenesis of the disease by jointly driving local ECM
fibres disruption and mechanical rupture. In a clinical perspective,
we conclude that the role of the local milieu in the develop-
ment/progression of abdominal wall impairment warrants further
investigation and will help in the development of more effective
prevention and new treatment strategies.
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